Bipolar Disorders Journal

•  
• Overview
•  
• Identity
•  
• View All
•  

Overview

publication venue for

• Biological rhythm disruptions in a school-based sample of children of mothers with bipolar disorder 2023
• Biological rhythms disruption mediates the association between mother's diagnosis of bipolar disorder and children's emotional and behavioral problems 2023
• Diet, nutrition, and eating behaviors in bipolar disorder: A narrative review from the ISBD nutrition and exercise task force (NEXT) 2023
• Early identification of bipolar disorder among young adults - a 22-year community birth cohort 2023
• Evaluation of mesencephalic astrocyte-derived neurotrophic factor serum levels in mood disorders 2023
• Functioning in older age bipolar disorder: limits and recommendations 2023
• Increased neurofilament light chain in individuals with bipolar disorder 2023
• Intranasal mesencephalic astrocyte-derived neurotrophic factor (MANF) as a novel treatment for bipolar disorder 2023
• Lifestyle modifications and non-pharmacological interventions to support perinatal mental health 2023
• Love and madness: Living with bipolar disorder 2023
• Mood symptoms and suicidality among offspring of mothers with bipolar disorder: A school-based sample 2023
• A novel neurobiological pathway behind psychosocial functioning in bipolar I disorder 2022
• A set of minimum data elements for prospective data collection among older age bipolar disorder (OABD) 2022
• Integrating biorhythm subtypes in a clinical subtype model of bipolar disorders 2022
• Tumor necrosis factor alpha and its association with bipolar disorder: A systematic review and meta-analysis 2022
• Bipolar disorder and frontotemporal dementia: A systematic review 2021
• Identifying nonlinear patterns of 5-year suicide risk incidence in youth: A gradient tree boosting and SHAP study 2021
• Lifestyle predictors of depression and anxiety during COVID-19: A machine learning approach 2021
• Mixed episodes and suicide risk: A community sample of young adults 2021
• Relationship between childhood trauma and inflammatory biomarkers in individuals with current depressive episodes 2021
• Relationships between affective, somatic, and cognitive symptoms against validated scores of anxiety and depression: A prospective preliminary study 2021
• Validating the 3-item biological rhythms interview of assessment in neuropsychiatry chronotype measure against actigraphy and the Munich chronotype questionnaire 2021
• Biological rhythms disruption in comorbid bipolar disorder and premenstrual dysphoric disorder 2020
• Chronobiologic assessment methods for bipolar disorders: current research protocols and clinical applications 2020
• Clozapine in bipolar disorder: A systematic review and meta-analysis 2020
• Cognitive complaints in mood disorders: A cross-sectional study 2020
• Daily variation of cognitive, affective and somatic factors that are related to mood disorders in adolescents 2020
• Functional impairment in a community sample of euthymic drug-free young adults with bipolar disorder 2020
• Functional impairment, biomarkers, and neuroprogression in bipolar disorder 2020
• Investigating light exposure and transition probabilities as variables of interest in mood disorders 2020
• Investigating the use of cannabinoids for insomnia in individuals with depression and anxiety 2020
• Modeling severity of postpartum depression using objective and subjective sleep and biological rhythms: A machine learning approach 2020
• Relationship between epigenetic markers and hypothalamus volumes in major depressive disorder 2020
• Resilience as a mediator factor in the relationship between childhood trauma and mood disorder: A community sample of young adults 2020
• Risk of dementia in bipolar disorder and the interplay of lithium: A systematic review and meta-analyses 2020
• The mood rhythm instrument: A chronobiological approach to evaluate mood in clinical settings 2020
• Diagnosis and treatment of women with co-morbid bipolar and premenstrual dysphoric disorder 2019
• Explicit emotional memory in major depressive disorder during euthymia 2019
• Intracortical Myelin as a novel neurobiological correlate of psychosocial functioning in bipolar I disorder 2019
• Lifetime cocaine use predicts conversion from major depressive disorder to bipolar disorder: A prospective 3-year follow-up study 2019
• Lithium blood monitoring practices in a Canadian population-based sample of older adults 2019
• Management of bipolar disorder in pregnancy and the postpartum period 2019
• Nutrition and Bipolar Disorders in Older Adults: A systematic Review 2019
• P2X7R participates in the pathophysiology of mania: A preclinical study 2019
• Predicting conversion to mood disorders in a cohort of bipolar offspring 2019
• Predicting functioning and quality of life using objective and subjective measures of sleep and biological rhythms in major depressive and bipolar disorder 2019
• Predictors of cognitive heterogeneity in a transcultural sample of individuals with bipolar disorder: A machine-learning approach 2019
• The impact of body mass index in gene expression of reelin pathway mediators in individuals with schizophrenia and mood disorders: A post-mortem study 2019
• The influence of endogenous DHEAS on mood in women with bipolar disorder with and without comorbid PMDD 2019
• Trauma, cocaine use and female sex predict transition from major depression to bipolar disorder 2019
• A biomarkers signature differentiates unipolar from bipolar depression 2018
• Brain structure and function in women with co-morbid bipolar and premenstrual dysphoric disorder 2018
• Correlations between endogenous hormones and resting-state functional connectivity in bipolar disorder with and without comorbid premenstrual dysphoric disorder 2018
• Differential biomarker signatures in unipolar and bipolar depression: A machine learning approach 2018
• Emotional memory in bipolar disorder and major depressive disorder: a preliminary report 2018
• Objective sleep and daytime activity in bipolar and major depressive disorder 2018
• The differential association between history of childhood sexual abuse and body mass index in early and late stages of bipolar disorder 2018
• The impact of big data analytics on bipolar disorder diagnosis 2018
• The impact of body mass index on gene expression of reelin pathway mediators in individuals with Schizophrenia and Mood disorders: a postmortem study 2018
• The impact of female reproductive life events on women with bipolar disorder: a clinical perspective 2018
• The transcription factor of the early growth response gene-3 (EGR-3) system as a target for immune intervention in bipolar disorder 2018
• VItex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review 2018
• A 24-week randomized, placebo-controlled trial of adjunctive tianeptine in the maintenance treatment of bipolar disorder 2017
• Anti-inflammatory drugs in the treatment of major depression: a systematic review 2017
• Biomarker signatures of bipolar disorder and schizophrenia 2017
• Changes in biological rhythms and mood from pregnancy to early postpartum in women with mood disorders: preliminary results 2017
• Circadian rhythmopathy - a shared timer for dopamine - dependent features in bipolar disorder? biological rhythms across the perinatal period in women with mood disorders: a longitudinal, replication and expansion study 2017
• Clinical outcomes in bipolar disorder and childhood trauma: a community sample of young adults 2017
• Clinical outcomes in subthreshold bipolar disorder: a community sample of young adults 2017
• Cognitive performance and mood disorders in a community sample of young adults 2017
• Concordance and discrepancy between subjective and objective cognitive assessment in bipolar disorder: what is influencing this discrepancy? 2017
• Earlier illness onset and increased hormonal sensitivity in women with co-morbid bipolar and premenstrual dysphoric disorder: clinical and treatment implications 2017
• Evidence of deficits in intracortical maturation in bipolar I disorder: a 3T MRI study 2017
• Global deficits in intracortical myelin maturation in young adults with bipolar I disorder 2017
• Increased illness burden in women with co-morbid bipolar and premenstrual dysphoric disorder: data from the large step-BD study 2017
• Neurobiological correlates of co-morbid bipolar and premenstrual dysphoric disorder 2017
• Serum of bipolar patients induces pro-inflammatory activation of macrophages 2017
• The Brazilian research network in bipolar disorder: main findings from the first 7 years of collaborative studies 2017
• Transdiagnostic aspects of peripheral biomarkers in major psychiatric disorders: a systematic review 2017
• Clinical correlates of general medical comorbidities in bipolar disorder 2016
• Diagnostic accuracy of measures evaluating premenstrual dysphoric disorder in women with comorbid bipolar and major depressive disorder 2016
• Inflammation and mitochondrial dysfunction in bipolar disorder 2016
• Intracortical myelin content in the DLPFC predicts verbal memory, and self-reported cognitive and psychosocial functioning in bipolar disorder 2016
• Objective parameters of sleep and circadian rhythms: an actigraph and melatonin study in bipolar and major depressive disorder 2016
• Prospective investigation of subjective measures of biological rhythms across the perinatal period in women with bipolar disorder 2016
• Resting state prefrontal cortical connectivity in women with bipolar disorder during euthymia: a seed-based analysis 2016
• Antidepressants in bipolar disorder why does the controversy continue? 2015
• Cerebral dopamine neurotrophic factor (CDNF) levels are increased in bipolar disorder 2015
• Child sexual abuse and suicidal attempts in Brazilian bipolar type I patients 2015
• Co-morbid bipolar and premenstrual dysphoric disorder: from hormones to brain circuits and behavior 2015
• Cortical thickness in bipolar disorder: a systematic review 2015
• Differences in resting state connectivity between follicular and luteal menstrual cycle phases in euthymic women with bipolar disorder 2015
• Longitudinal assessment of circadian rhythms in women at risk for postpartum depression 2015
• MAC-PMSS: preliminary analyses of a new DSM-5-based tool to monitor concurrent mood and premenstrual symptoms 2015
• Microglial activation and inflammation in bipolar disorder 2015
• Women with history of mood disorders show greater circadian rhythm disruption across the perinatal period: preliminary analyses of a longitudinal study 2015
• Abstracts 2014
• Bipolar disorder vs disruptive mood dysregulation disorder: MRI studies 2014
• Circadian rhythm disruption in women with bipolar and premenstrual dysphoric disorder during remission: preliminary results 2014
• Correlation between peripheral BDNF levels and hippocampus volume in children and adolescents with bipolar disorder 2014
• Does pregnancy affect circadian rhythms in women with mood disorders during remission? 2014
• Hippocampal volumes are correlated to inflammatory markers in early stage bipolar disorder 2014
• Oxidative stress and inflammation in bipolar disorder: the putative role of activated microglial cells 2014
• Profile of disability in bipolar affective disorder and interplay of social factors: policy and treatment design relevance in a developing context 2014
• Serum myelin oligodendrocyte glycoprotein levels are stable in depressed females with bipolar disorder 2014
• Staging and profiling bipolar disorder: clinical and neurobiological approaches 2014
• Staging and profiling: complementary approaches to improve treatment 2014
• Staging bipolar disorder: clinical, biochemical, and functional correlates 2014
• A double challenge: pregnancy and post-partum in bipolar disorder 2013
• Association of obesity with reduced hippocampal volume in bipolar disorder 2013
• Biomarkers and clinical staging 2013
• Circadian rhythm is a strong predictor of quality of life in females with bipolar disorder 2013
• Coping skills and functioning in first-degree relatives of bipolar disorder patients - preliminary data 2013
• Differential early attachment characteristics in schizophrenic and bipolar disorder patients 2013
• Early apoptosis in peripheral blood mononuclear cells from patients with bipolar disorder: preliminary results 2013
• Early life trauma, inflammation and mood disorders in young adults from the general population 2013
• Gender differences in bipolar disorder evaluated by inductive logic programming approach 2013
• How do patients defend themselves from bipolar disorder? 2013
• Impaired endoplasmic reticulum stress response in bipolar disorder: cellular evidence of illness progression 2013
• Inductive logic programming approach analysis in bipolar disorder - pilot study 2013
• Longitudinal assessment of changes in circadian rhythms and risk for postpartum depression: a preliminary analysis 2013
• Markers of lipid peroxidation are not altered in depressed and euthymic females with bipolar disorder 2013
• Peripheral eotaxin-1 (CCL11) levels and mood disorder diagnosis in a population-based sample of young adults 2013
• Prodromal mood symptoms and inflammatory markers in first-degree relatives of patients with bipolar disorder: preliminary data 2013
• VaI66Met polymorphism and longitudinal changes in serum brain-derived neurotrophic factor along treatment of medication-free patients with bipolar disorder 2013
• A functional MRI investigation of the neural correlates of declarative and recognition memory in obese patients with bipolar disorder 2012
• A nested population-based case-control study on peripheral inflammation markers and brain-derived neurotrophic factor in early-stage mood disorders 2012
• Analysis of mitochondrial complexes activity in peripheral blood mononuclear cells of bipolar disorder, schizophrenic and healthy subjects 2012
• BDNF levels in first-degree relatives of patients with bipolar disorder: preliminary data 2012
• Bipolar disorder treatment: implications from the staging model perspective 2012
• Brain-Derived Neurotrophic Factor in Juvenile Bipolar Disorder and Attention-Deficit Hyperactivity Disorder: differentiation using BDNF serum levels, and Val66Met 2012
• Clinical characteristics and pattern of drug use in a population of crack cocaine users with and without mood disorders 2012
• Default mode network in children at risk for bipolar disorder: preliminary resting-state fMRI findings 2012
• Delay in bipolar disorder treatment is correlated to an adverse course of illness 2012
• Impact of first-episode polarity on clinical features associated to suicide attempts in bipolar disorder type I patients 2012
• Role of biomarkers in the staging of bipolar disorder: inflammatory factors and oxidative stress 2012
• Sensitivity and specificity of the Mood Disorders Questionnaire as a screening for bipolar disorder during pregnancy and postpartum 2012
• Significance of homocysteine to the cardiovascular risk in bipolar disorder 2012
• The staging model of bipolar disorder and cognitive functioning: a comparison with patients with schizophrenia 2012
• A longitudinal assessment of serum Brain Derived Neurotrophic Factor levels in bipolar patients 2011
• Alterations in cytokine and adipokine levels over two years of follow up in first episode patients with bipolar disorder 2011
• Clinical characteristics of suicide attempters among bipolar disorder patients - results from the Brazilian Research Consortium for Bipolar Disorders 2011
• Comparison between clinical characteristics of suicide attempters and non-attempters in a sample of bipolar disorder patients with mania as first episode polarity 2011
• Comparison of creatine kinase levels in depressed, manic and euthymic patients with bipolar disorder 2011
• Daytime sleepiness, sleep disturbance and functioning impairment in bipolar disorder 2011
• Effects of sodium butyrate on d-amphetamine-induced oxidative stress in the rat brain 2011
• Gender differences in bipolar disorder: finding from the Brazilian Bipolar Research Network 2011
• Impact of migraine comorbidity in the clinical course of bipolar disorder 2011
• Internalized stigma in bipolar disorder type I (INTEST-BD I) project: comparison of internalized stigma in a sample of young adults and chronic outpatients with bipolar disorder type I 2011
• Low prevalence of alcohol use disorders in Brazilian bipolar disorder patients: results from the Brazilian Bipolar Research Network 2011
• N-acetyl cysteine (NAC) as an adjunctive therapy for bipolar depression 2011
• Neuroanatomical profile of antimaniac effects of histone deacetylases inhibitors 2011
• Abnormalities in serum chemokines levels in euthymic patients with bipolar disorder 2010
• Allostatic load in bipolar disorder 2010
• Alterations in levels of cytokines and adipokines over two-year follow-up in patients with bipolar disorder 2010
• Attention deficit and psychopathology in children victims of trauma 2010
• BDNF levels in the rat prefrontal cortex, amygdala and hippocampal CA3 region in an animal model of mania 2010
• Brain-derived neurotrophic factor as a possible biomarker of bipolar disorder activity 2010
• Brain-derived neutrotrophic in mania, depression, and euthymia in bipolar disorders: a systematic review and meta-analysis 2010
• Cognitive assessment in a crack users population with and without mood disorders: a pilot study 2010
• Comparison between clinical characteristics of suicide attempters and non-attempters in a sample of bipolar disorder patients with mania as first episode polarity 2010
• Comparison of creatine kinase levels in depressed, manic, and euthymic patients with bipolar disorder 2010
• Comparison of cytokine levels in depressed, manic, and euthymic patients with bipolar disorder 2010
• Complement system in bipolar disorders and schizophrenia: C3 and C4 2010
• Correlation between serum brain-derived neurotrophic factor and neurotrophin-3 levels in bipolar disorder 2010
• Decreased cellular viability in SH-SY5Y neuroblastoma cell line induced by incubation with serum from manic bipolar patients 2010
• Early life stress does not alter global DNA methylation in the striatum of an animal model of mania 2010
• Effect of mood stabilizers on behavioral and manic-like symptoms secondary to herpes simplex encephalitis: a case report 2010
• Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain 2010
• Effects of sodium butyrate and tamoxifen on creatine kinase activity in an animal model of mania 2010
• Functional impairment and disability across mood states in subjects with bipolar disorder 2010
• Making sense of findings of brain imaging in bipolar disorder 2010
• Mass spectrometry of synaptosome after treatment with m-amphetamine as a potential means to investigate the pathophysiology of bipolar disorder 2010
• Neurotrophin-3 is increased in patients with bipolar disorder on and off medication during manic and depressive episodes 2010
• Psychiatric hospitalizations due to bipolar disorder, major depression disorder, and schizophrenia in Rio Grande do Sul, Brazil 2010
• Serum thiobarbituric acid reactive substances in bipolar disorder during mania and schizophrenia: a biomarker with possible diagnostic implications 2010
• Stigma and functioning in patients with bipolar disorders 2010
• The International Society for Bipolar Disorders (ISBD) Task Force on the Nomenclature of Course and Outcome in Bipolar Disorders 2010
• Brain-derived neurotrophic factor levels and cognitive dysfunction in euthymic bipolar type I patients 2009
• DNA damage and apoptosis in bipolar and schizophrenia patients 2009
• Decreased serum brain-derived neurotrophic factor in unmedicated and medicated bipolar patients during manic and depressive episodes 2009
• Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats 2009
• Predictors of functional impairment in bipolar disorder: clinical factors 2009
• Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): A pilot study in drug resistant depressed patients 2009
• Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus 2008
• Brain creatine kinase activity in an animal model of mania 2008
• Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal BDNF protein levels 2008
• Effects of N-acetylcysteine and/or deferoxamine on oxidative stress and hyperactivity in an animal model of mania 2008
• Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania 2008
• Oxidative stress markers in bipolar disorder: A meta-analysis 2008
• The international society of bipolar disorders task force on the nomenclature of course and outcome in bipolar disorders 2008
• Pathophysiology of cognitive impairment in bipolar disorders 2007
• Adaptation and validation of the Portuguese version of the functional assessment short test (FAST) in bipolar patients 2007
• Effects of lithium and valproate on DNA damage and oxidative stress markers in an animal model 2007
• Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in bipolar disorder during mood episodes and in schizophrenia 2007
• Functional impairment in patients with remitted bipolar disorder 2007
• Is neurotrophin-3 involved in bipolar disorder? Data from animal and human studies 2007
• Prevalence of metabolic syndrome in never treated mood disordered patients 2007
• Psychological interventions for bipolar disorder reduces the recurrence of new episodes: a systematic review and meta-analysis 2007
• Rates of obesity in a never treated population with mood disorders: baseline incidence and change over four years of follow-up 2007
• Relevance of allostasis and allostatic load in bipolar disorder 2007
• Suicidal behavior among bipolar patients at a primary care setting 2007
• Superior antimanic efficacy of allopurinol compared to dipyridamol and placebo as add-on treatment to lithium in unmedicated bipolar patients during a mania episode: a double-blind placebo-controlled trial 2007
• The use of clozapine in the treatment of bipolar disorder in a patient with clinical comorbidities 2007
• A twin-case study of oxidative stress and DNA damage in bipolar disorder 2006
• Alcohol consumption and suicidal behaviour in bipolar disorder 2006
• Increased oxidative stress status in bipolar disorder 2006
• Neuroleptic malignant syndrome associated with olanzapine 2006
• Quality of life and anxious comorbidity in bipolar patients 2006
• Serum content of GDNF is increased during manic and depressive episodes 2006
• Suicidal behavior and anxiety comorbidity affect psychosocial disability in bipolar disorder 2006
• A double-blind controlled study of adjunctive allopurinol or dipyridamole to lithium in the treatment of bipolar mania: preliminary results 2005
• Neurochemical evaluation of neurotrophic factors and markers of neuronal damage during manic episode in drug naive and lithium treated subjects: the possible role of severity of symptoms 2005
• Prevalence of metabolic syndrome in never treated mood disordered patients 2005
• Early intervention, relapse prevention, and neuroprogression in bipolar disorder: The evidence matters.  26:313-316. 2024
• Supporting career development for early‐ and mid‐career professionals working in the bipolar disorder field: Key initiatives to be implemented by the International Society for Bipolar Disorders Early‐ and Mid‐Career Committee.  26:211-215. 2024
• Fostering networking opportunities and creating a community of early and mid‐career clinicians and researchers within the International Society for Bipolar Disorders.  26:186-187. 2024
• Quality of laboratory biomarker monitoring during treatment with lithium in patients with bipolar disorder.  25:499-506. 2023
• The Early Mid‐Career Committee (EMCC) of the International Society for Bipolar Disorders: Aspirations and goals.  24:781-783. 2022
• Smartphone‐based interventions in bipolar disorder: Systematic review and meta‐analyses of efficacy. A position paper from the International Society for Bipolar Disorders (ISBD) Big Data Task Force.  24:580-614. 2022
• Network properties of intracortical myelin associated with psychosocial functioning in bipolar I disorder.  24:539-548. 2022
• Conversion to major neurocognitive disorder after COVID‐19 in a woman with bipolar disorder: A 6‐year longitudinal case report.  24:451-456. 2022
• Biological underpinnings for the association between substance use and bipolar disorder.  24:227-228. 2022
• Neurobiological and behavioral mechanisms of circadian rhythm disruption in bipolar disorder: A critical multi‐disciplinary literature review and agenda for future research from the ISBD task force on chronobiology.  24:232-263. 2022
• Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations.  23:767-788. 2021
• The importance of countertransference in the clinical care of individuals during acute phases of bipolar disorder.  23:850-851. 2021
• Consensus on nomenclature for clinical staging models in bipolar disorder: A narrative review from the International Society for Bipolar Disorders (ISBD) Staging Task Force.  23:659-678. 2021
• Why do medications with little or no efficacy continue to be prescribed in the management of patients with bipolar disorder?.  23:541-543. 2021
• Clozapine for bipolar disorder: What do we know so far and what next?.  23:115-116. 2021
• Novel mechanism of action for the mood stabilizer lithium.  23:76-83. 2021
• Measuring circadian function in bipolar disorders: Empirical and conceptual review of physiological, actigraphic, and self‐report approaches.  22:693-710. 2020
• Call to action regarding the vascular‐bipolar link: A report from the Vascular Task Force of the International Society for Bipolar Disorders.  22:440-460. 2020
• Current understandings of the trajectory and emerging correlates of cognitive impairment in bipolar disorder: An overview of evidence.  22:13-27. 2020
• Machine learning and big data analytics in bipolar disorder: A position paper from the International Society for Bipolar Disorders Big Data Task Force.  21:582-594. 2019
• Differences between unipolar mania and bipolar‐I disorder: Evidence from nine epidemiological studies.  21:437-448. 2019
• Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.  20:97-170. 2018
• A pilot, open‐label, 8‐week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression.  19:198-213. 2017
• Resting state functional connectivity in women with bipolar disorder during clinical remission.  19:97-106. 2017
• Brain‐derived neurotrophic factor, impaired glucose metabolism, and bipolar disorder course.  18:373-378. 2016
• Cortical thickness in bipolar disorder: a systematic review.  18:4-18. 2016
• Sex hormones and biomarkers of neuroprotection and neurodegeneration: implications for female reproductive events in bipolar disorder.  16:48-57. 2014
• Response to commentaries on the Canadian Network for Mood and Anxiety Treatments/International Society for Bipolar Disorders 2013 updated Bipolar Disorder Guidelines.  15:338-339. 2013
• Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.  15:1-44. 2013
• The evolution of CANMAT Bipolar Disorder Guidelines: past, present, and future.  15:58-60. 2013
• Impact of sunlight on the age of onset of bipolar disorder.  14:654-663. 2012
• Six‐month functional outcome of a bipolar disorder cohort in the context of a specialized‐care program.  13:679-686. 2011
• Problems with single‐factor solutions in factor analyses of low‐end scores.  11:900-900. 2009
• Cognitive function and serum levels of brain‐derived neurotrophic factor in patients with bipolar disorder.  11:663-671. 2009
• The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders.  11:453-473. 2009
• Clinical predictors of functional outcome of bipolar patients in remission.  11:401-409. 2009
• Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.  11:225-255. 2009
• Brain‐derived neurotrophic factor in bipolar disorder: beyond trait and state: comment on ‘Decreased levels of serum brain‐derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders’.  11:221-222. 2009
• Corrected values of brain metabolites for the article: ‘Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication‐free individuals with bipolar disorder: an in vivo¹H MRS study’.  10:849-849. 2008
• Letter to the Editor: Agomelatine adjunctive therapy for acute bipolar depression: preliminary open data.  10:749-750. 2008
• Coping styles in prodromes of bipolar mania.  9:589-595. 2007
• Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication‐free individuals with bipolar disorder: an in vivo¹H MRS study.  9:119-127. 2007
• Traumatic life events in bipolar disorder: impact on BDNF levels and psychopathology.  9:128-135. 2007
• Cognitive-behavioral therapy for bipolar disorders in adolescents: a pilot study..  8:508-515. 2006
• Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania.  8:275-280. 2006
• CANMAT guidelines for bipolar disorder: a commentary from South America.  7:87-88. 2005
• Longitudinal outcome in patients with bipolar disorder assessed by life‐charting is influenced by DSM‐IV personality disorder symptoms.  5:14-21. 2003

has subject area

• 1103 Clinical Sciences (FoR)
• 1109 Neurosciences (FoR)
• Psychiatry (Science Metrix)

Identity

International Standard Serial Number (ISSN)

• 1398-5647

Electronic International Standard Serial Number (EISSN)

• 1399-5618